ArticleAmerican journal of hematology2015

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old.

Neha Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.